Biotechnology Index NYSE ETF (FBT)

$160.39 0.00 (0.00%)

20:00 EDT FBT Stock Quote Delayed 30 Minutes

7 Biotech Stocks To Buy For Profit From The Vaccine Crunch

By Tezcan Gecgil, InvestorPlace Contributor Oct 7, 2020

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.

3 Healthcare ETFs to Buy for Health and Safety

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

7 Equal-Weighted Index Funds to Buy for 2020 and Beyond

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 160.39 - 160.39

52-Week Range 140.06 - 186.51

Dividend & Yield N/A (N/A)

FBT Stock Predictions, Articles, and Biotechnology Index NYSE ETF News

From InvestorPlace
From the Web

7 of the Best Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Feb 27, 2019

Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.

7 Biotech ETFs to Consider for 2019

By Todd Shriber, InvestorPlace Contributor Nov 20, 2018

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

9 ETF Winners From 9-Year Bull Run

By Zacks Investment Research Mar 9, 2018

We have presented a bunch of top-performing ETFs of the nine-year bull market that will continue to outperform in the coming months. Compare Brokers...

4 Hot Sector ETFs Springing Up to Rank #1

By Zacks Investment Research Mar 8, 2018

A number of funds in their respective sectors have seen their Ranks surging to the top hierarchy and could make great spring picks. Compare Brokers...

The 10 Best ETFs of January 2018

By Robert Waldo, InvestorPlace Web Editor Feb 2, 2018

These were the some of the best ETFs in January. Each outperformed the S&P 500 by at least 5% or more. Here's what investors need to know about each ETF.

Sector ETF and Stock Winners in the 10 Years Since the Great Recession

By Zacks Investment Research Dec 7, 2017

While most of the sectors have flourished over the past decade, consumer discretionary and information technology have led the way .

Is Now the Time to Buy Into These 5 Biotech ETFs?

By Zacks Investment Research Mar 14, 2017

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

Bet on a Bounce with These Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Oct 13, 2015

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.

The Best Way to Buy Biotech Stocks: A Heated Debate

By Todd Shriber, InvestorPlace Contributor Aug 28, 2015

Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers.

The Best ETFs of 2014

By Aaron Levitt, InvestorPlace Contributor Dec 30, 2014

Sure, you're going to see biotech atop this list of the year's best ETFs ... but a couple of market areas boasted funds with head-scratchingly high returns.

Looking For the Best ETFs to Buy? Read On.

By Will Ashworth, InvestorPlace Contributor Oct 1, 2014

The best ETFs in Q3 were sectors and countries rather than broader markets. Three ETFs from China, Middle East and biotech come to mind.

3 Ways to Play Healthcare’s Hot Stocks

By David Fabian, FMD Capital Management Jul 24, 2014

Broad plays on healthcare stocks have done well historically, but investors can get some significant juice out of more targeted plays.

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover

From Benzinga Dec 14, 2020

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-...

ETF Sectors to Bet on Positive Vaccine News

From Talk Markets Nov 28, 2020

The aggravating coronavirus outbreak in the United States and globally is definitely increasing the desperation for a vaccine

Large Cap Biopharma Performance and Metrics Q3 2020; ETFs Are Winners

From Talk Markets Nov 24, 2020

Surging coronavirus infections has even nicked the healthcare sector down 3% for the week.

Election History Says Buy Biotech Dip

From Benzinga Sep 9, 2020

Biotechnology exchange-traded funds were hot until they weren't. History indicates recent weakness in the previously high-flying group be a symptom of election year jitters...

Post-Pandemic Stars Could Align For This Biotech ETF

From Benzinga Aug 11, 2020

These days, it's not hard to find winners among health care exchange-traded funds and that's true of both established and rookie players. What Happened: Obviously, the...

Red Hot ETF Areas Amid The Coronavirus Crisis

From Talk Markets Aug 2, 2020

Some ETF areas that will continue to be strong investing options through the pandemic will be internet, biotech and sustainable investing ETFs.